Picture of Oncolytics Biotech logo

ONCY — Oncolytics Biotech News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Brief: Oncolytics Biotech Inc announces FDA fast track designation for Reolysin

May 8 (Reuters) - Oncolytics Biotech Inc  ONC.TO :  
    * Oncolytics Biotech Inc announces FDA fast track 
designation for Reolysin in metastatic breast cancer 
    * Oncolytics Biotech-based on co's understanding of 
Reolysin, is pursuing metastatic breast cancer as its primary 
focus for late-stage clinical testing 
 
Source text for Eikon:  ID:nPnbghvf3a  
Further company coverage:  ONC.TO  
 
 ((Bangalore.newsroom@thomsonreuters.com;))

Recent news on Oncolytics Biotech

See all news